Literature DB >> 9482693

Calcium-dependent phospholipase A2 mediates the production of endothelium-derived hyperpolarizing factor in perfused rat mesenteric prearteriolar bed.

A S Adeagbo1, M K Henzel.   

Abstract

The isolated, perfused rat mesenteric bed releases a cytochrome P450-linked metabolite of arachidonic acid (AA) as endothelium-derived hyperpolarizing factor (EDHF) in response to acetylcholine and histamine. This study assessed the relative contribution of two AA-generating pathways, phospholipase A2 (PLA2) and diacylglycerol (DAG) lipase, to EDHF-mediated dilation of the rat mesenteric bed. We tested the hypothesis that PLA2-mediated release of AA is essential for the production of EDHF. Mesenteric beds were perfused with physiological salt solution (PSS) containing indomethacin and nitro-L-arginine methyl ester to block cyclooxygenase and nitric oxide synthase, respectively, and constricted with cirazoline (an alpha1-adrenoceptor agonist). Bolus applications of acetylcholine and histamine caused dose-dependent dilation of the constricted beds. The 85-kDa PLA2 inhibitor, arachidonyl trifluoromethyl ketone (AACOCF3), at 3 microM, profoundly blunted decreases in perfusion pressure initiated by 1 nmol acetylcholine (94.3+/-1.7%) and by 100 nmol histamine (88.5+/-3.3%) to 9.6+/-7.5 and 8.6+/-6.0%, respectively. AACOCF3 also blocked cirazoline-stimulated release of 6-keto-PG1alpha, but did not alter the vasodilation initiated by sodium nitroprusside (a nitric oxide donor), cromakalim (a K+ channel activator), or by Na+/K+-ATPase activation, as measured by KCl vasodilation in preconstricted beds perfused with K+-free PSS. The 14-kDa PLA2 inhibitor, oleyloxyethyl phosphorylcholine, also blocked EDHF vasodilation and also significantly inhibited K+ channel activity. Neither the Ca2+-independent PLA2 inhibitor, HELSS [E-6-(bromomethylene)-tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one], nor DAG lipase inhibitor, RHC-80267 [1,6-bis-(cyclohexyloximino-carbonylamino)-hexane] altered EDHF-mediated vasodilation. However, RHC-80267 blocked cirazoline-stimulated release of 6-keto-PGF1alpha. We conclude that Ca2+-dependent PLA2, rather than DAG lipase, generates the AA for the production of EDHF in the perfused rat mesenteric bed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482693     DOI: 10.1159/000025562

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  7 in total

1.  Apamin-sensitive, non-nitric oxide (NO) endothelium-dependent relaxations to bradykinin in the bovine isolated coronary artery: no role for cytochrome P450 and K+.

Authors:  G R Drummond; S Selemidis; T M Cocks
Journal:  Br J Pharmacol       Date:  2000-02       Impact factor: 8.739

2.  Endothelium-derived hyperpolarizing factor but not NO reduces smooth muscle Ca2+ during acetylcholine-induced dilation of microvessels.

Authors:  S S Bolz; C de Wit; U Pohl
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

3.  Ca(2+) influx in the endothelial cells is required for the bradykinin-induced endothelium-dependent contraction in the porcine interlobar renal artery.

Authors:  E Ihara; D N Derkach; K Hirano; J Nishimura; H Nawata; H Kanaide
Journal:  J Physiol       Date:  2001-08-01       Impact factor: 5.182

4.  The endothelial component of cannabinoid-induced relaxation in rabbit mesenteric artery depends on gap junctional communication.

Authors:  A T Chaytor; P E Martin; W H Evans; M D Randall; T M Griffith
Journal:  J Physiol       Date:  1999-10-15       Impact factor: 5.182

Review 5.  Endothelium-dependent smooth muscle hyperpolarization: do gap junctions provide a unifying hypothesis?

Authors:  Tudor M Griffith
Journal:  Br J Pharmacol       Date:  2004-03       Impact factor: 8.739

6.  Reactive oxygen species facilitate the EDH response in arterioles by potentiating intracellular endothelial Ca(2+) release.

Authors:  James Chidgey; Paul A Fraser; Philip I Aaronson
Journal:  Free Radic Biol Med       Date:  2016-06-16       Impact factor: 7.376

Review 7.  Cirrhotic portal hypertension: From pathophysiology to novel therapeutics.

Authors:  Lakmie S Gunarathne; Harinda Rajapaksha; Nicholas Shackel; Peter W Angus; Chandana B Herath
Journal:  World J Gastroenterol       Date:  2020-10-28       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.